Postmarketing Surveillance Study of Atrovent® Inhalation Solution in Chronic Obstructive Pulmonary Disease

NCT02238197 · clinicaltrials.gov ↗

COMPLETED

Status

477

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Atrovent® Inhalation Solution

Sponsor

Boehringer Ingelheim